Home » Topics » BioWorld Science

BioWorld Science
RSS

Hyanalgese-D demonstrates negative efficacy in U.S. phase III trial

Aug. 23, 1996

KF-20444: Kyowa Hakko's novel antirheumatic agent

Aug. 23, 1996

Protease inhibitors from Sankyo

Aug. 23, 1996

Biaxin shown to prolong longetivity in AIDS patients

Aug. 23, 1996

Zerit launched in U.K.

Aug. 23, 1996

Zithromax demonstrates prophylactic effect against MAC in AIDS patients

Aug. 23, 1996

Epivir approved for European market

Aug. 23, 1996

Norvir approved by Canadian authorities

Aug. 23, 1996

Dainabot seeks Japanese approval of Norvir

Aug. 23, 1996

Roxane Laboratories has begun U.S. nevirapine distribution

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...